Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials
Authors:
- Marta Mascareñas‐GarcíaMMMarta Mascareñas‐García
- Alejandro Rivero‐De‐AguilarARAlejandro Rivero‐De‐Aguilar
- Cristina Candal‐PedreiraCCCristina Candal‐Pedreira
- Guadalupe GarcíaGGGuadalupe García
- Carla Guerra‐TortCGCarla Guerra‐Tort
- Lucía Martín‐GisbertLMLucía Martín‐Gisbert
- Julia Rey‐BrandarizJRJulia Rey‐Brandariz
- Mónica Pérez‐Ríos RíosMRMónica Pérez‐Ríos Ríos
- Beatriz Casal‐AcciónBCBeatriz Casal‐Acción
- María Isolina Santiago‐PérezMSMaría Isolina Santiago‐Pérez
- Leonor Varela‐LemaLVLeonor Varela‐Lema
Open Access
- 26 January 2026
- journal article
- Published by Wiley in Annals of Neurology
- Vol. 99 (2) , 316-327
Abstract
Objective: Spin refers to reporting strategies that highlight the benefits of an experimental treatment or divert attention from nonsignificant primary outcomes. We aimed to assess spin in randomized controlled trials (RCTs) on pharmaceutical efficacy in multiple sclerosis (MS) and explore associated factors. Methods: A systematic literature search was conducted in MedLine (PubMed), EMBASE, and Cochrane using database‐specific thesauri (“Multiple Sclerosis” and “Drug Therapy”) to identify relevant studies. We included multiple sclerosis phase 3 and 4 randomized controlled trials with parallel, superiority designs that were published between 2013 and 2024 reporting nonsignificant primary outcomes. Spin was assessed in title, abstract conclusion, results, discussion, and conclusions. A descriptive analysis was followed by exploratory bivariate logistic regression. Independent variables included trial phase, sample size, drug type, comparison, follow‐up time, registration, Consolidated Standards of Reporting Trials (CONSORT) mention, risk of bias (RoB2), journal quartile, first author affiliation, and conflict of interest. Results: Forty articles met inclusion criteria. Spin appeared in at least one section in 25 articles (62.5%) and in 3 or more in 19 articles (47.5%). The most frequent locations were abstract conclusions, discussion, and conclusions. Spin was significantly associated with smaller sample size (odds ratio [OR] = 7.00, 95% confidence interval [CI] = 1.29–37.91, p = 0.024), non‐Q1 journals (OR = 4.38, 95% CI = 1.03–18.63, p = 0.046), and first author affiliation outside Europe or the United States (OR = 5.09, 95% CI = 1.15–22.62, p = 0.032). Interpretation: Spin is common in MS randomized controlled trials with nonsignificant primary outcomes and may mislead clinical decisions. ANN NEUROL 2026;99:316–327Keywords
This publication has 31 references indexed in Scilit:
- Analysis of spin in vascular surgery randomized controlled trials with nonsignificant outcomesJournal of Vascular Surgery, 2022
- Methodological aspects of superiority, equivalence, and non-inferiority trialsInternal and Emergency Medicine, 2020
- How do journals of different rank instruct peer reviewers? Reviewer guidelines in the field of managementScientometrics, 2020
- Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trialsEPMA Journal, 2019
- Level and Prevalence of Spin in Published Cardiovascular Randomized Clinical Trial Reports With Statistically Nonsignificant Primary OutcomesJAMA Network Open, 2019
- Evaluation of spin in the abstracts of otolaryngology randomized controlled trialsThe Laryngoscope, 2018
- World Map of Scientific MisconductScience and Engineering Ethics, 2017
- Power failure: why small sample size undermines the reliability of neuroscienceNature Reviews Neuroscience, 2013
- Reporting and Interpretation of Randomized Controlled Trials With Statistically Nonsignificant Results for Primary OutcomesJAMA, 2010
- The Order of Authorship: Who's on First?JAMA, 1990